PQ 804
804. Deputy Micheál Carrigy asked the Minister for Health the policy rationale for the continued exclusion of sarcoidosis from the HSE long-term illness scheme; if she will acknowledge that Ireland has one of the highest global prevalence rates of sarcoidosis, yet patients face an annual out-of-pocket cost of up to €960 under the drugs payment scheme for essential medications; and if her Department will update the statutory list of 16 conditions under the Health Act 1970 to include sarcoidosis. [47508/26]
Introduced
23 June 2026
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
23 June 2026
Summary
804. Deputy Micheál Carrigy asked the Minister for Health the policy rationale for the continued exclusion of sarcoidosis from the HSE long-term illness scheme; if she will acknowledge that Ireland has one of the highest global prevalence rates of sarcoidosis, yet patients face an annual out-of-pocket cost of up to €960 under the drugs payment scheme for essential medications; and if her Department will update the statutory list of 16 conditions under the Health Act 1970 to include sarcoidosis. [47508/26]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Health Services
Health Services
xml · EN · 23 June 2026
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2026-06-23/804/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2026-06-23/pq_804